Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Green Valley Stops Global Phase III Trial of its Novel China-Approved Alzheimer’s Drug

publication date: May 16, 2022

Green Valley Pharmaceuticals has stopped the international Phase III trial for its Alzheimer’s disease treatment, citing difficulties caused by COVID and the current “funding winter” of raising capital. Green Valley’s Alzheimer’s therapy was granted a surprise China approval in 2019, the first new AD treatment in 16 years. GV-971, a product derived from seaweed, has a unique mechanism that targeted gut biota to prevent the buildup of amyloid/tau related tangles in the brain. Following China approval, Green Valley started a global five-year Phase III  trial in over 2,000 people to internationalize its novel therapy. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital